1. Home
  2. CMPX vs CTW Comparison

CMPX vs CTW Comparison

Compare CMPX & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

N/A

Current Price

$0.77

Market Cap

154.9M

Sector

Health Care

ML Signal

N/A

Logo CTW Cayman Class A Ordinary Shares

CTW

CTW Cayman Class A Ordinary Shares

N/A

Current Price

$1.81

Market Cap

171.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CMPX
CTW
Founded
2014
2013
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
154.9M
171.0M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
CMPX
CTW
Price
$0.77
$1.81
Analyst Decision
Buy
Analyst Count
15
0
Target Price
★ $5.46
N/A
AVG Volume (30 Days)
★ 3.8M
13.3K
Earning Date
11-13-2026
10-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$22.41
Revenue Growth
N/A
★ N/A
52 Week Low
$0.73
$1.10
52 Week High
$6.88
$3.14

Technical Indicators

Market Signals
Indicator
CMPX
CTW
Relative Strength Index (RSI) 27.17 40.00
Support Level N/A $1.19
Resistance Level $2.02 $1.88
Average True Range (ATR) 0.05 0.32
MACD 0.03 -0.00
Stochastic Oscillator 24.94 24.32

Price Performance

Historical Comparison
CMPX
CTW

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

About CTW CTW Cayman Class A Ordinary Shares

CTW operates as a gaming platform company providing instant access to free-to-play, browser-based games inspired by popular Japanese animation, including "So I'm a Spider, So What? Ruler of the Labyrinth, Arifureta: From Commonplace to World's Strongest - Rebellion Soul", and "Queen's Blade Limit Break". CTW delivers these games through its flagship HTML5 platform, G123.jp.

Share on Social Networks: